BRCA2 and breast carcinoma: used a modified segregation analysis approach to determine that the age-specific risk of breast cancer among female mutation carriers overlaps the risk conferred by BRCA2 mutations [5] establishing that, despite the rarity of mutations, PALB2 is the most significant breast cancer predisposition gene after BRCA1 and BRCA2.